Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations
@article{TCR99394,
author = {Rahul Kumar and Emily Miao and Luke Roy George Pike},
title = {Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations},
journal = {Translational Cancer Research},
volume = {14},
number = {4},
year = {2025},
keywords = {},
abstract = {},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/99394}
}